Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 4:2019:3791061.
doi: 10.1155/2019/3791061. eCollection 2019.

Combined Administration of Streptozotocin and Sucrose Accelerates the Appearance of Type 2 Diabetes Symptoms in Rats

Affiliations

Combined Administration of Streptozotocin and Sucrose Accelerates the Appearance of Type 2 Diabetes Symptoms in Rats

Martha Isela Barragán-Bonilla et al. J Diabetes Res. .

Abstract

Type 2 diabetes is a disease with a high global prevalence, characterized by chronic hyperglycemia, insulin resistance, polyphagia, polydipsia, polyuria, and changes in body weight. Animal models have been very useful for the study of this disease and to search for new therapeutic targets that delay, attenuate, or avoid diabetic complications. The purpose of this work was to establish a model of type 2 diabetes and exhibit the majority of the characteristics of the disease. Two-day-old male and female Wistar rats were treated once with streptozotocin (70 or 90 mg/kg body weight). After weaning, they were given a sucrose-sweetened beverage (SSB; sucrose at 10 or 30%) during 7 or 11 weeks; their body weight and food intake were measured daily. With the rats at 14 weeks of age, we determined the following: (a) fasting blood glucose, (b) oral glucose tolerance, and (c) insulin tolerance. We found that the supplementation of sucrose at 10% for 7 weeks in male rats which had previously been given streptozotocin (70 mg/kg) at neonatal stage leads to the appearance of the signs and symptoms of the characteristic of type 2 diabetes in adulthood.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Experimental scheme of diabetes induction in Wistar rats. Two-day-old male and female rats were injected with STZ (70 or 90 mg/kg) intraperitoneally (i.p.). The rats were immediately returned to their mothers and weaned at 21 days of age. In addition, rat groups with and without 70 mg of STZ/kg body weight were supplemented with SSB (standard commercial sucrose) at 10% or 30% for either 7 or 11 weeks after weaning. The Control group was included that was not exposed to STZ nor to SSB. Body weight and food intake were monitored daily for 6 weeks (when the rats were 8-14 weeks of age), and fasting blood glucose was measured at weeks 10 and 14 of age. Afterward, the insulin tolerance test (ITT) and glucose tolerance test (GTT) were performed at week 14.

References

    1. American Diabetes Association. 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S13–S27. doi: 10.2337/dc18-S002. - DOI - PubMed
    1. International Diabetes Federation. IDF Diabetes Atlas. 8th. Brussels, Belgium: International Diabetes Federation; 2017. - PubMed
    1. King A. J. F. The use of animal models in diabetes research. British Journal of Pharmacology. 2012;166(3):877–894. doi: 10.1111/j.1476-5381.2012.01911.x. - DOI - PMC - PubMed
    1. Islam M. S., Koya D., Portha B. Animal models of diabetes and its associated complications. Journal Diabetes Research. 2013;2013:p. 1. doi: 10.1155/2013/593204. - DOI - PMC - PubMed
    1. Eleazu C. O., Eleazu K. C., Chukwuma S., Essien U. N. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. Journal of Diabetes & Metabolic Disorders. 2013;12(1):p. 60. doi: 10.1186/2251-6581-12-60. - DOI - PMC - PubMed